Cyprotex Launches Improved Version of SenCeeTox®

PETA UK funded initial validation studies of SenCeeTox^®, an in vitro model for the assessment of skin sensitisation. Cyprotex PLC purchased this method from its developers, made significant improvements to the method, and re-released it this week. Click here for more details.